Registration closes 10 September for the 5th Immuno-Metabolic Mechanisms of Atherosclerosis Conference in Playa del Carmen, Mexico. Join Senior Scientific Editor Laura Corradi at the upcoming @Fusion_Conf meeting! Register here: bit.ly/4xGP11M #IMMA

Announcing Nature Progress Oncology! An open-access journal in the new Nature Progress series, publishing significant advances in cancer research, from cell biology and immunology, therapeutics, clinical research, and epidemiology nature.com/natprogoncology

Announcing Nature Progress Brain Health! A new open-access journal bringing together timely research across the full landscape of brain health, including preclinical and translational neuroscience, neurology, and neuropsychiatry nature.com/natprogbrainhealt…

🧬 Don’t miss the 2nd Meeting on Epigenetics & Epigenomics in Health & Disease! Our editor Dr P. Mallini will be there. 📅Sept 24–26, 2025 | 📍Brussels 🔗xcellsconferences.com/epigen… #Epigenetics2025 #Epigenomics

@AlbertoArdid and colleagues present new work in which they use transfer machine learning methods that help forecasting volcanic eruptions, also at less monitored volcanoes. nature.com/articles/s41467-0…

Dr. Peter Attia and team from Glimpse battery industry provide us insightful discussions on challenges and opportunities for high-quality battery production at scale doi.org/10.1038/s41467-025-5… #battery

Here @georgebiggs94 @KatrinRittinger, @Jake_T_Bush, @TheCrick present a label-free chemoproteomics platform using data-independent acquisition to profile covalent fragment binding across the human proteome. nature.com/articles/s41467-0…

Researchers @pnnlab report a robust, easy-to-use single voxel proteomics technique for deep proteome mapping of tissues and profiling of regions of interest. nature.com/articles/s41467-0…

Authors @kribler, David Baker, colleagues from @Uwproteindesign and colaboratorrs present a method for creating pseudosymmetric hetero-oligomers from input symmetrical proteins. nature.com/articles/s41467-0…

In this work, the authors at @hantschel_lab develop mirror-image monobodies (Mb) made of D-amino acids against the BCR::ABL1 SH2 domain. The D-Mbs are protease-resistant, inhibit BCR::ABL1 kinase activity and bind BCR::ABL1 in cell lysates. nature.com/articles/s41467-0…